Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin vs UFH for Pulmonary Thromboembolism
NCT00796692Phase 4Completed
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Jun 2002
- Primary completion
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nadroparin in pulmonary thromboembolism (PE), sponsored by Beijing Chaoyang Hospital. Started Jun 2002; status: completed.
02
Drugs
nadroparin
03
Conditions
pulmonary thromboembolism (PE)
Beyond the preview
Go deeper on NCT00796692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796692.